Massively Parallel Sequencing Approaches for Characterization of Structural Variation
The emergence of next-generation sequencing (NGS) technologies offers an incredible opportunity to comprehensively study DNA sequence variation in human genomes. Commercially available platforms from Roche (454), Illumina (Genome Analyzer and Hiseq 2000), and Applied Biosystems (SOLiD) have the capability to completely sequence individual genomes to high levels of coverage. NGS data is particularly advantageous for the study of structural variation (SV) because it offers the sensitivity to detect variants of various sizes and types, as well as the precision to characterize their breakpoints at base pair resolution. In this chapter, we present methods and software algorithms that have been developed to detect SVs and copy number changes using massively parallel sequencing data. We describe visualization and de novo assembly strategies for characterizing SV breakpoints and removing false positives.
- Preclinical Study Design for rAAV
- Measuring Nucleosome Occupancy In Vivo by Micrococcal Nuclease
- Profiling of Epstein-Barr Virus Latent RNA Expression in Clinical Specimens by Gene-Specific Multiprimed cDNA Synthesis and PCR
- Measurement of Precursor miRNA in Exosomes from Human ESC-Derived Mesenchymal Stem Cells
- Naturally Occurring Minichromosome Platforms in Chromosome Engineering: An Overview
- j5 DNA Assembly Design Automation
- The Detection of Point Mutations in Hemoglobin Defects Using Allele-Specific Oligonucleotide Probes
- Molecular Analysis of Mitochondrial DNA Point Mutations by Polymerase Chain Reaction
- The Use of a Flagellar Export Signal for the Secretion of Recombinant Proteins in Salmonella
- An Oligonucleotide Crosslinking Assay for the Analysis of Individual DrugBinding Sites